您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[美股财报]:Harrow Health Inc 2024年度报告 - 发现报告

Harrow Health Inc 2024年度报告

2025-03-27美股财报车***
Harrow Health Inc 2024年度报告

FORM10-K (Mark One)☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year endedDecember 31,2024 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF1934 For the transition period from to Commission File Number:001-35814 HARROW, INC.(Exact name of registrant as specified in its charter) 1A Burton Hills Blvd.,Suite 200Nashville,TN37215(Address of Principal Executive Offices)(Zip Code) (615)733-4730(Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.Yes☒No☐ ☐No☒ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),and (2) has been subject to such filing requirements for the past 90 days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§ 229.405 of this chapter) during the preceding 12 months (or for such shorter period that theregistrant was required to submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smallerreporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one): Accelerated filer☒Smaller reporting company☒ Large accelerated filer☐Non-accelerated filer☐ Emerging growth company☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectivenessof its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registeredpublic accounting firm that prepared or issued its audit report.☒ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of theregistrant included in the filing reflect the correction of an error to previously issued financial statements.☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-basedcompensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b).☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes☐No☒ As of June 28, 2024, the last business day of the registrant’s most recently completed second fiscal quarter, the aggregate market valueof the common stock held by non-affiliates of the registrant was approximately $678million, based on the closing price of $20.89 forthe registrant’s common stock as quoted on The Nasdaq Stock Market LLC on that date. For purposes of this calculation, it has beenassumed that shares of common stock held by each director, each officer and each person who owns 10% or more of the outstandingcommon stock of the registrant are held by affiliates of the registrant. The treatment of these persons as affiliates for purposes of thiscalculation is not conclusive as to whether such persons are affiliates of the registrant for any other purpose. As of March 26, 2025, there were35,654,171shares of the registrant’s common stock outstanding. Portions of the registrant’s definitive Proxy Statement for its 2025 Annual Meeting of Stockholders to be held on June 18, 2025 areincorporated by reference in Part III of this Annual Report on Form 10-K, to the extent stated herein. TABLE OF CONTENTS PagePART I4Item 1.Business4Item 1A.Risk Factors19Item 1B.Unresolved Staff Comments52Item 1C.Cybersecurity52Item 2.Properties53Item 3.Legal Proceedings53Item 4.Mine Safety Disclosures53 PART II53Item 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities53Item 6.[Reserved]54Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations55Item 7A.Quantitative and Qualitative Disclosures About Market Risk67Item 8.Financial Statements and Supplementary Data67Item 9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosure67Item 9A.Controls and Procedures68Item 9B.Other Information69Item 9C.Disclosure Regarding Foreign Jurisdictions that Prevent Inspec